{"transactions":[{"id":1661470,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:10:45.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2024, such that all of the shares shall be fully vested and exercisable on January 1, 2027, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":6.76,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-24-010491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024010491/ownership.xml","form_type":"4"}},{"id":1681524,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-10T21:29:56.000Z","date":"2024-01-09","kind":"sale","planned":false,"acquired":false,"shares":14391,"price":4.37,"value":62888.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 16,500 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020 and 10,808 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $4.02 to $4.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":371248,"source":{"system":"sec-edgar","filing":"0000950170-24-003648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024003648/ownership.xml","form_type":"4"}},{"id":2028302,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T21:21:26.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":6.77,"expiration_date":"2033-02-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-007513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123007513/doc4.xml","form_type":"4"}},{"id":2056414,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-11T21:09:38.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":45907,"price":5.24,"value":240552.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 62,500 shares of Common Stock underlying RSUs granted to the Reporting Person on January 7, 2019, 16,500 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, and 10,808 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $5.11 to $5.37 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":385639,"source":{"system":"sec-edgar","filing":"0001209191-23-002979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123002979/doc4.xml","form_type":"4"}},{"id":2202770,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-22","kind":"exercise","acquired":false,"shares":6246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.7,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":6246},"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202769,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-21","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested."}],"balance_after":6246,"derivative":{"exercise_price":2.7,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202768,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":620,"price":33.28,"value":20633.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202767,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":2703,"price":32.61,"value":88144.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share."}],"balance_after":432166,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202766,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":2923,"price":31.33,"value":91577.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share."}],"balance_after":434869,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202765,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-22","kind":"exercise","acquired":true,"shares":6246,"price":2.7,"value":16864.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":437792,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202764,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-21","kind":"sale","acquired":false,"shares":19171,"price":33.07,"value":633984.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202763,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-21","kind":"sale","acquired":false,"shares":10829,"price":32.54,"value":352375.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6."}],"balance_after":450717,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2202762,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T22:18:08.000Z","date":"2022-07-21","kind":"exercise","acquired":true,"shares":30000,"price":2.7,"value":81000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":461546,"source":{"system":"sec-edgar","filing":"0001209191-22-043143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122043143/doc4.xml","form_type":"4"}},{"id":2291073,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-22","kind":"exercise","acquired":false,"shares":10000,"price":2.7,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested."}],"balance_after":36246,"derivative":{"exercise_price":2.7,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291072,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-21","kind":"exercise","acquired":false,"shares":30000,"price":2.7,"value":81000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested."}],"balance_after":46246,"derivative":{"exercise_price":2.7,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291071,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-22","kind":"sale","acquired":false,"shares":838,"price":35.15,"value":29455.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold from $35.04 to $35.29 per share."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291070,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-22","kind":"sale","acquired":false,"shares":9162,"price":34.54,"value":316455.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold from $34.04 to $35.03 per share."}],"balance_after":432384,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291069,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-22","kind":"exercise","acquired":true,"shares":10000,"price":2.7,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":441546,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291068,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-21","kind":"sale","acquired":false,"shares":1003,"price":37.9,"value":38013.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $37.70 to $38.38 per share."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291067,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-21","kind":"sale","acquired":false,"shares":2220,"price":36.7,"value":81474.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $36.29 to $37.08 per share."}],"balance_after":432549,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291066,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-21","kind":"sale","acquired":false,"shares":4062,"price":35.73,"value":145135.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $35.29 to $36.25 per share."}],"balance_after":434769,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291065,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-21","kind":"sale","acquired":false,"shares":22715,"price":34.57,"value":785257.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $34.22 to $35.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7."}],"balance_after":438831,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2291064,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T20:11:06.000Z","date":"2022-04-21","kind":"exercise","acquired":true,"shares":30000,"price":2.7,"value":81000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":461546,"source":{"system":"sec-edgar","filing":"0001209191-22-025515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122025515/doc4.xml","form_type":"4"}},{"id":2411580,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T22:59:41.000Z","date":"2022-01-21","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Corrected ending balance of this option which includes 36,800 shares that are vested and outstanding pursuant to a second option grant issued on January 12, 2016."}],"balance_after":76246,"derivative":{"exercise_price":2.7,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-004871","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322004871/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-24"}},{"id":2411579,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T22:59:41.000Z","date":"2022-01-20","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Corrected option price."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Corrected ending balance of this option which includes 36,800 shares that are vested and outstanding pursuant to a second option grant issued on January 12, 2016."}],"balance_after":86246,"derivative":{"exercise_price":2.7,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-004871","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322004871/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-24"}},{"id":2411578,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-04T22:59:41.000Z","date":"2022-01-20","kind":"exercise","acquired":true,"shares":30000,"price":2.7,"value":81000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Corrected option price."}],"balance_after":461546,"source":{"system":"sec-edgar","filing":"0000899243-22-004871","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322004871/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-24"}},{"id":2423941,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T21:09:49.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":289403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":289403,"derivative":{"exercise_price":39.87,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":289403},"source":{"system":"sec-edgar","filing":"0000899243-22-003426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322003426/doc4.xml","form_type":"4"}},{"id":2427698,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-24T21:36:34.000Z","date":"2022-01-21","kind":"exercise","acquired":false,"shares":10000,"price":2.7,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":89446,"derivative":{"exercise_price":2.7,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-004606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122004606/doc4.xml","form_type":"4"}},{"id":2427697,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-24T21:36:34.000Z","date":"2022-01-20","kind":"exercise","acquired":false,"shares":30000,"price":2.73,"value":81900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":20000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-004606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122004606/doc4.xml","form_type":"4"}},{"id":2427696,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-24T21:36:34.000Z","date":"2022-01-21","kind":"sale","acquired":false,"shares":10000,"price":38.02,"value":380200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-004606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122004606/doc4.xml","form_type":"4"}},{"id":2427695,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-24T21:36:34.000Z","date":"2022-01-21","kind":"exercise","acquired":true,"shares":10000,"price":2.7,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":441546,"source":{"system":"sec-edgar","filing":"0001209191-22-004606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122004606/doc4.xml","form_type":"4"}},{"id":2427694,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-24T21:36:34.000Z","date":"2022-01-20","kind":"sale","acquired":false,"shares":30000,"price":40.21,"value":1206300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-004606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122004606/doc4.xml","form_type":"4"}},{"id":2427693,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-24T21:36:34.000Z","date":"2022-01-20","kind":"exercise","acquired":true,"shares":30000,"price":2.73,"value":81900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":461546,"source":{"system":"sec-edgar","filing":"0001209191-22-004606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122004606/doc4.xml","form_type":"4"}},{"id":2435887,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-13T21:09:01.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":4519,"price":49.07,"value":221747.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 16,500 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 10,807 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $48.70 to $49.40 per share."}],"balance_after":431546,"source":{"system":"sec-edgar","filing":"0001209191-22-003174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003174/doc4.xml","form_type":"4"}},{"id":2435886,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-13T21:09:01.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":10047,"price":48.5,"value":487279.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 16,500 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 10,807 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $47.70 to $48.69 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":436065,"source":{"system":"sec-edgar","filing":"0001209191-22-003174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003174/doc4.xml","form_type":"4"}},{"id":2436740,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-12T21:07:58.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":101,"price":47.72,"value":4819.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 62,500 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":446112,"source":{"system":"sec-edgar","filing":"0001209191-22-003054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003054/doc4.xml","form_type":"4"}},{"id":2436739,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-12T21:07:58.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":20894,"price":47.17,"value":985569.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 62,500 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $46.72 to $47.67 per share."}],"balance_after":446213,"source":{"system":"sec-edgar","filing":"0001209191-22-003054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003054/doc4.xml","form_type":"4"}},{"id":2436738,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-12T21:07:58.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":13161,"price":46.36,"value":610143.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 62,500 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $45.72 to $46.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":467107,"source":{"system":"sec-edgar","filing":"0001209191-22-003054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003054/doc4.xml","form_type":"4"}},{"id":2500636,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-22T22:45:38.000Z","date":"2021-11-18","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":79446,"derivative":{"exercise_price":2.7,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-066168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121066168/doc4.xml","form_type":"4"}},{"id":2500635,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T22:45:38.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":86475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement."}],"balance_after":480268,"source":{"system":"sec-edgar","filing":"0001209191-21-066168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121066168/doc4.xml","form_type":"4"}},{"id":2500634,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T22:45:38.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":20000,"price":54.27,"value":1085400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-066168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121066168/doc4.xml","form_type":"4"}},{"id":2500633,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T22:45:38.000Z","date":"2021-11-18","kind":"exercise","acquired":true,"shares":20000,"price":2.7,"value":54000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":413793,"source":{"system":"sec-edgar","filing":"0001209191-21-066168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121066168/doc4.xml","form_type":"4"}},{"id":2535477,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":15154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":99446,"derivative":{"exercise_price":2.7,"expiration_date":"2026-01-11","underlying":"Common Stock","underlying_shares":15154},"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535476,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":4846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.835,"expiration_date":"2025-01-04","underlying":"Common Stock","underlying_shares":4846},"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535475,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":50000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535474,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-21","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":60000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535473,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":30000,"price":58.88,"value":1766400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535472,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":15154,"price":2.7,"value":40915.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535471,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":4846,"price":4.84,"value":23454.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":408639,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535470,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":403793,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535469,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":14765,"price":60.63,"value":895201.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.31 to $61.26 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535468,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":15235,"price":59.82,"value":911357.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.31 to $60.30 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":408558,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2535467,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T20:04:34.000Z","date":"2021-10-21","kind":"exercise","acquired":true,"shares":30000,"price":2.73,"value":81900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0001209191-21-061485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121061485/doc4.xml","form_type":"4"}},{"id":2594749,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-20T20:02:41.000Z","date":"2021-08-19","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":4846,"derivative":{"exercise_price":4.835,"expiration_date":"2025-01-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-052744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121052744/doc4.xml","form_type":"4"}},{"id":2594748,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-20T20:02:41.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":20000,"price":88.0102,"value":1760204.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-052744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121052744/doc4.xml","form_type":"4"}},{"id":2594747,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-20T20:02:41.000Z","date":"2021-08-19","kind":"exercise","acquired":true,"shares":20000,"price":4.835,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":413793,"source":{"system":"sec-edgar","filing":"0001209191-21-052744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121052744/doc4.xml","form_type":"4"}},{"id":2624811,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-23","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":24846,"derivative":{"exercise_price":4.835,"expiration_date":"2025-01-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624810,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":90000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624809,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-22","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":100000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624808,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-23","kind":"sale","acquired":false,"shares":30000,"price":85.2846,"value":2558538.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624807,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-23","kind":"exercise","acquired":true,"shares":20000,"price":4.84,"value":96800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624806,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-23","kind":"exercise","acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":403793,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624805,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-22","kind":"sale","acquired":false,"shares":1600,"price":86.9026,"value":139044.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $86.76 to $87.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624804,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-22","kind":"sale","acquired":false,"shares":21773,"price":86.1944,"value":1876710.6712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $85.76 to $86.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":395393,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624803,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-22","kind":"sale","acquired":false,"shares":6627,"price":85.3811,"value":565820.5497,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $84.76 to $85.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":417166,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2624802,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-26T20:05:21.000Z","date":"2021-07-22","kind":"exercise","acquired":true,"shares":30000,"price":2.73,"value":81900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0000899243-21-029868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321029868/doc4.xml","form_type":"4"}},{"id":2698739,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T20:01:55.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":44846,"derivative":{"exercise_price":4.835,"expiration_date":"2025-01-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-035301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121035301/doc4.xml","form_type":"4"}},{"id":2698738,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-05-24T20:01:55.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":20000,"price":77.1646,"value":1543292.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-035301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121035301/doc4.xml","form_type":"4"}},{"id":2698737,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-05-24T20:01:55.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":20000,"price":4.835,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":413793,"source":{"system":"sec-edgar","filing":"0001209191-21-035301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121035301/doc4.xml","form_type":"4"}},{"id":2739572,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"exercise","acquired":false,"shares":5154,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":64846,"derivative":{"exercise_price":4.835,"expiration_date":"2025-01-04","underlying":"Common Stock","underlying_shares":5154},"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739571,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"exercise","acquired":false,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.62,"expiration_date":"2024-01-08","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739570,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"exercise","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":130000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739569,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-22","kind":"exercise","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":140000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739568,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":30000,"price":85.2428,"value":2557284.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739567,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"exercise","acquired":true,"shares":5154,"price":4.835,"value":24919.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739566,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"exercise","acquired":true,"shares":14846,"price":6.62,"value":98280.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":418639,"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739565,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-23","kind":"exercise","acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":403793,"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739564,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-22","kind":"sale","acquired":false,"shares":30000,"price":85.5404,"value":2566212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2739563,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-04-26T20:03:22.000Z","date":"2021-04-22","kind":"exercise","acquired":true,"shares":30000,"price":2.73,"value":81900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0001209191-21-028259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121028259/doc4.xml","form_type":"4"}},{"id":2845997,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"exercise","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested."}],"balance_after":14846,"derivative":{"exercise_price":6.62,"expiration_date":"2024-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2845996,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":5547,"price":103.1559,"value":572205.7773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $102.86 to $103.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2845995,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":8602,"price":102.2624,"value":879661.1648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $101.85 to $102.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":399340,"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2845994,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":2602,"price":101.4156,"value":263883.3912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $100.83 to $101.82 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":407942,"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2845993,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1848,"price":100.4821,"value":185690.9208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $99.825 to $100.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":410544,"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2845992,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1401,"price":99.0842,"value":138816.9642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $98.65 to $99.645 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":412392,"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2845991,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-02-19T21:07:51.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":20000,"price":6.62,"value":132400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":413793,"source":{"system":"sec-edgar","filing":"0001209191-21-012326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121012326/doc4.xml","form_type":"4"}},{"id":2899115,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"This option is fully vested."}],"balance_after":34846,"derivative":{"exercise_price":6.62,"expiration_date":"2024-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899114,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"This option is fully vested."}],"balance_after":170000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899113,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"This option is fully vested."}],"balance_after":180000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899112,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":16441,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The shares subject to this option shall vest in 48 equal monthly installments beginning on February 1, 2021 such that this option is fully exercisable on January 1, 2025."}],"balance_after":16441,"derivative":{"exercise_price":109.01,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":16441},"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899111,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":3075,"price":100.0146,"value":307544.895,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents the weighted average sale price of the shares sold ranging from $99.81 to $100.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899110,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":6520,"price":99.3454,"value":647732.008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents the weighted average sale price of the shares sold ranging from $98.80 to $99.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":396868,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899109,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":7638,"price":98.4488,"value":751951.9344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents the weighted average sale price of the shares sold ranging from $97.80 to $98.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":403388,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899108,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":12767,"price":97.2337,"value":1241382.6479,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price of the shares sold ranging from $96.77 to $97.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":411026,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899107,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":20000,"price":6.62,"value":132400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":423793,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899106,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":403793,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899105,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":200,"price":106.955,"value":21391.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of the shares sold ranging from $106.84 to $107.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":393793,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899104,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":645,"price":106.0338,"value":68391.801,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of the shares sold ranging from $105.75 to $106.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":393993,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899103,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":4271,"price":105.2486,"value":449516.7706,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of the shares sold ranging from $104.75 to $105.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":394638,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}},{"id":2899102,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":94666,"kind":"person","name":"Wolchko J Scott","position":1,"cik":"0001586893","reported_name":"Wolchko J Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock","published_at":"2021-01-22T23:23:42.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":9156,"price":104.1326,"value":953438.0856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold ranging from $103.74 to $104.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":398909,"source":{"system":"sec-edgar","filing":"0001209191-21-004957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004957/doc4.xml","form_type":"4"}}],"next_cursor":"2021-01-22T23:23:42.000000Z,2899102"}